NIH-FDA Tobacco Control Regulatory Research
93.077
The Family Smoking Prevention and Tobacco Control Act (TCA) provides the authority to regulate tobacco product manufacturing, distribution and marketing. Regulatory research will provide the scientific evidence to guide the implementation of this authority. Research areas include: 1) tobacco product composition and design 2), the toxicity of tobacco products, 3) addiction and abuse liability of tobacco products, 4) the short- and long-term health effects of tobacco products, 5) people’s behaviors related to tobacco product use and characteristics, 6) communicating to the public regarding nicotine and the health effects of tobacco products, 7) the influences of tobacco marketing on susceptibility and tobacco product use, and 8) the potential or actual impact of FDA regulatory actions. The strategic priorities for these research areas can be found at https://www.fda.gov/tobacco-products/research/research-priorities.
This chart shows obligations for the program by fiscal year. All data for this chart was provided by the
administering agency and sourced from SAM.gov, USASpending.gov, and Treasury.gov.
For more information on each of these data sources, please see the
About the data page.
Single Audit Applies (2 CFR Part 200 Subpart F):
For additional information on single audit requirements for this program, review the current Compliance Supplement.
OMB is working with the U.S. Government Accountability Office (GAO) and agency offices of inspectors general to include links to relevant oversight reports. This section will be updated once this information is made available.